CrusoniaWhy this is inevitable.
Crusonia is not a bet that the world changes. It's a recognition that it already has. Eight forces are converging on the same point, and none of them reverses.
The pre-chronic majority
88% of American adults carry some degree of metabolic dysfunction, most of it undiagnosed and most of it felt. These are people who aren't sick enough for the system to bill yet, but are done waiting to be. They are the largest, most motivated health market in history, and the current system has no product for them.
The GLP-1 shockwave
The drugs settled the argument: metabolism is the lever, and the country will pay enormous sums to pull it. But a drug priced forever, for everyone, is a bill no payer can carry. Every payer doing that math arrives at the same question: what delivers the outcome at a fraction of the cost? Food. GLP-1s didn't compete with food as health. They priced it.
Reversal at retail
Produce prescriptions are dropping A1C, ER visits, and total cost of care in the real world, today. Retailers are waking up to the highest-margin product they've ever carried: the health outcome. When the grocery store becomes a care setting, the channel inverts.
Measurement got cheap
CGMs, wearables, and longitudinal data made metabolic health visible at the individual level for the first time. Once you can measure it, you can attribute it. Once you can attribute it, you can price it. The entire outcomes economy was waiting on this one capability, and it arrived.
Intelligence got cheap
The old system's silos weren't malice; they were coordination costs. AI is collapsing the cost of coordination toward zero: connecting soil data to clinical outcomes to actuarial tables to capital, work that once took institutions and decades. And as AI agents begin handling food decisions and purchasing, the brand moat that protected the incumbent shelf starts to drain.
The soil signal
Agricultural science can now measure what farming practices do to the nutrient density of food, which connects the farm to the body with data for the first time. Value that always existed in the field becomes capturable, and the supply chain reorganizes toward it.
The policy turn
Food and health agencies are collaborating on chronic disease for the first time in living memory: dietary guidance redesigned around whole foods, scrutiny of ultra-processed food and ingredient self-certification rising across both parties. Policy doesn't lead transitions. It ratifies them. The ratification has begun.
The cost wall
Healthcare spending compounds faster than the economy that pays for it, against an aging population that wants years of quality, not years of treatment. Employers, payers, and government are all converging on the same arithmetic: the only sustainable cost curve is the one bent upstream. This force doesn't persuade. It compels.
Direction is settled. Timing is the variable.
Any one of these forces would mark a shift. All eight, converging, mark a transition: the kind that happens slowly and then all at once. The physics are settled. The tools are in hand. The only variable left is the density of people who act on it.
That's the part you can change.